NCT03523715

Brief Summary

This is a prospective, randomized control trial that randomizes patients post-operatively into standard care versus standard care plus prunes. Patients in the control arm will take 100 mg docusate twice per day for 3 days (standard care). Participants in the treatment arm will consume 4 oz prunes daily and take 100 mg docusate twice per day for 3 days. The primary objective is to determine the time to first bowel movement after surgery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
77

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Nov 2017

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 30, 2017

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 1, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 14, 2018

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2020

Completed
8 months until next milestone

Results Posted

Study results publicly available

April 8, 2021

Completed
Last Updated

April 8, 2021

Status Verified

March 1, 2021

Enrollment Period

2.6 years

First QC Date

May 1, 2018

Results QC Date

March 11, 2021

Last Update Submit

March 11, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Time to First Bowel Movement

    Time to first bowel movement after surgery

    3 days

Secondary Outcomes (6)

  • Stool Consistency of the First Bowel Movement

    3 days

  • Pain With Bowel Movement Measured

    3 days

  • Satisfaction With Bowel Regimen

    3 day

  • Satisfaction With Surgery Overall

    3 days

  • Requirements for Laxatives

    3 days

  • +1 more secondary outcomes

Study Arms (2)

Prunes

EXPERIMENTAL

The study group will be instructed to consume 4 oz of prunes as well as docusate sodium twice daily for 3 days after surgery.

Dietary Supplement: PrunesDrug: Docusate Sodium

Control

PLACEBO COMPARATOR

The placebo group will be instructed to take docusate sodium twice daily for 3 days after surgery.

Drug: Docusate Sodium

Interventions

PrunesDIETARY_SUPPLEMENT

12 oz of prunes daily

Also known as: Dried plums
Prunes

Oral docusate sodium twice daily

Also known as: Colace
ControlPrunes

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female patients seen in the Gynecology or Urogynecology clinics at LAC+USC Medical Center who are planned for surgery requiring at least 24 hour stay
  • Age 18 or greater
  • Able to give informed consent
  • No contraindications to docusate or prune consumption

You may not qualify if:

  • Unable to give informed consent
  • Unwilling to follow protocol
  • Active malignancy
  • Emergency surgery
  • Diabetes mellitus
  • Inflammatory bowel disease, gastroparesis, or other bowel disorder
  • History of bowel resection or presence of colostomy
  • Dependence on regular laxative use prior to surgery
  • Baseline frequency of bowel movements less than weekly
  • Intraoperative enterotomy or any bowel surgery performed at the time of surgery
  • Patient unable to initiate oral intake on post op day 1 for any reason
  • Allergy to docusate or prunes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Los Angeles Count + USC Medical Center

Los Angeles, California, 90033, United States

Location

Related Publications (6)

  • Patel M, Schimpf MO, O'Sullivan DM, LaSala CA. The use of senna with docusate for postoperative constipation after pelvic reconstructive surgery: a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol. 2010 May;202(5):479.e1-5. doi: 10.1016/j.ajog.2010.01.003. Epub 2010 Mar 6.

    PMID: 20207340BACKGROUND
  • McNanley A, Perevich M, Glantz C, Duecy EE, Flynn MK, Buchsbaum G. Bowel function after minimally invasive urogynecologic surgery: a prospective randomized controlled trial. Female Pelvic Med Reconstr Surg. 2012 Mar-Apr;18(2):82-5. doi: 10.1097/SPV.0b013e3182455529.

    PMID: 22453316BACKGROUND
  • Lever E, Cole J, Scott SM, Emery PW, Whelan K. Systematic review: the effect of prunes on gastrointestinal function. Aliment Pharmacol Ther. 2014 Oct;40(7):750-8. doi: 10.1111/apt.12913. Epub 2014 Aug 11.

    PMID: 25109788BACKGROUND
  • Lever E, Scott SM, Louis P, Emery PW, Whelan K. The effect of prunes on stool output, gut transit time and gastrointestinal microbiota: A randomised controlled trial. Clin Nutr. 2019 Feb;38(1):165-173. doi: 10.1016/j.clnu.2018.01.003. Epub 2018 Feb 15.

    PMID: 29398337BACKGROUND
  • Attaluri A, Donahoe R, Valestin J, Brown K, Rao SS. Randomised clinical trial: dried plums (prunes) vs. psyllium for constipation. Aliment Pharmacol Ther. 2011 Apr;33(7):822-8. doi: 10.1111/j.1365-2036.2011.04594.x. Epub 2011 Feb 15.

    PMID: 21323688BACKGROUND
  • Rasouli MA, Dancz CE, Dahl M, Volpe KA, Horton CJ, Ozel BZ. Effect of prunes on gastrointestinal function after benign gynecological surgery: a randomized control trial. Langenbecks Arch Surg. 2022 Dec;407(8):3803-3810. doi: 10.1007/s00423-022-02584-8. Epub 2022 Jun 22.

MeSH Terms

Conditions

Constipation

Interventions

Dioctyl Sulfosuccinic Acid

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

SuccinatesDicarboxylic AcidsAcids, AcyclicCarboxylic AcidsOrganic Chemicals

Results Point of Contact

Title
Begum Ozel, MD
Organization
University of Southern California

Study Officials

  • Begum Ozel, MD

    Keck School of Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 1, 2018

First Posted

May 14, 2018

Study Start

November 30, 2017

Primary Completion

June 30, 2020

Study Completion

July 31, 2020

Last Updated

April 8, 2021

Results First Posted

April 8, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations